🇺🇸 FDA

Intelligence · Patent portfolio

Chongqing Precision Biotech Patents

Full USPTO pharma patent portfolio for Chongqing Precision Biotech — grant dates, expiration, and drug cross-links.

Patents
158
Expiring ≤24m
2

Quick answer

Chongqing Precision Biotech has 158 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 2 expire within 24 months — use filters for patent-cliff planning.

Page 1 of 4

  1. US 12419920

    Bifidobacterium longum NCIMB 41676

    Expires Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12410418

    Optimized engineered meganucleases having specificity for a recognition sequence in the Hepatitis B virus genome

    Expires Mon Sep 04 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12351839

    Rationally-designed single-chain meganucleases with non-palindromic recognition sequences

    Expires Mon Jul 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12344676

    Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers

    Expires Mon Jun 26 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12336835

    Neuromodulation to target glucose transporter and/or incretin pathways

    Expires Mon Jun 19 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 12233135

    Therapeutic constructs for treating cancer

    Expires Mon Feb 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 12232492

    Disinfection of bacteriophages products using supercritical carbon dioxide

    Expires Mon Feb 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 12180463

    Lactobacillus reuteri

    Expires Mon Dec 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 12162920

    Hinge area and use of same in constructing car skeleton

    Expires Mon Dec 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 12071516

    Polymeric stabilizing formulations

    Expires Mon Aug 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 12054501

    Compositions and methods for inhibiting arginase activity

    Expires Mon Aug 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 12037410

    Methods and compositions for targeting Treg cells

    Expires Mon Jul 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 12029577

    Neuromodulation to target glucose transporter and/or incretin pathways

    Expires Mon Jul 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 12012597

    Cancer treatment using siRNA to modulate expression of PRDM2/RIZ protein

    Expires Mon Jun 13 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 12006522

    Polynucleotides encoding engineered meganucleases having specificity for recognition sequences in the dystrophin gene

    Expires Mon Jun 06 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 11993793

    Polynucleotides encoding engineered meganucleases having specificity for recognition sequences in the dystrophin gene

    Expires Mon May 23 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 11952429

    Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers

    Expires Mon Apr 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 11931453

    Drug delivery device

    Expires Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 11866747

    Engineered meganucleases that target human mitochondrial genomes

    Expires Mon Jan 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 11851680

    Genetically-modified immune cells comprising a microRNA-adapted shRNA (shRNAmiR)

    Expires Mon Dec 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 11826392

    Purification method of fungal cell wall composition

    Expires Mon Nov 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 11790574

    System and method for carbon dioxide angiographic roadmap imaging

    Expires Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 11788141

    MVD as epigenetic marker for the identification of immune cells, in particular CD56+ NK cells

    Expires Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 11788077

    Polynucleotides encoding optimized engineered meganucleases having specificity for a recognition sequence in the Hepatitis B virus genome

    Expires Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 11786554

    Optimized engineered nucleases having specificity for the human T cell receptor alpha constant region gene

    Expires Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 11771723

    Bifidobacterium longum NCIMB 41676

    Expires Mon Sep 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 11767367

    Monoclonal antibody neo-201 for the treatment of human carcinomas

    Expires Mon Sep 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 11753630

    Polynucleotides encoding engineered meganucleases having specificity for recognition sequences in the dystrophin gene

    Expires Mon Sep 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 11680254

    Engineered meganucleases specific for recognition sequences in the PCSK9 gene

    Expires Mon Jun 15 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 11679159

    Compositions for transfecting resistant cell types

    Expires Mon Jun 15 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 11590179

    Bifidobacterium longum able to beneficially modulate immune response to respiratory virus infection

    Expires Mon Feb 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 11572575

    Compositions for transfecting resistant cell types

    Expires Mon Feb 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 11572413

    Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers

    Expires Mon Feb 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 11529381

    Bifidobacterium longum able to beneficially modulate immune response to respiratory virus infection

    Expires Mon Dec 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 11505604

    Humanized monoclonal antibodies and methods of use for the diagnosis and treatment of colon and pancreas cancer

    Expires Mon Nov 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 11490643

    Lactobacillus casei for treating obesity and associated metabolic disorders

    Expires Mon Nov 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 11478430

    Implantable medical devices for extended release of therapeutic agents

    Expires Mon Oct 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 11453861

    Genetically-modified immune cells comprising a microRNA-adapted shRNA (shRNAmiR)

    Expires Mon Sep 22 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 11401341

    Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers

    Expires Mon Jul 28 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 11400123

    Combination product for prophylaxis and treatment of irritable bowel syndrome

    Expires Mon Jul 28 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 11384335

    Genetically-modified immune cells comprising a microRNA-adapted shRNA (shRNAmiR)

    Expires Mon Jul 07 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 11345733

    Colon and pancreas cancer specific antigens and antibodies

    Expires Mon May 26 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 11317888

    Non-invasive method for pressure measurement

    Expires Mon Apr 28 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 11286291

    Co-stimulatory domains for use in genetically-modified cells

    Expires Mon Mar 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 11278632

    Engineered nucleases useful for treatment of hemophilia A

    Expires Mon Mar 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 11279768

    Anti-cancer antibodies, combination therapies, and uses thereof

    Expires Mon Mar 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 11274285

    Engineered meganucleases specific for recognition sequences in the Hepatitis B virus genome

    Expires Mon Mar 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 11266693

    Nucleic acids encoding engineered meganucleases with recognition sequences found in the human T cell receptor alpha constant region gene

    Expires Mon Mar 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Chongqing Precision Biotech have?

158 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Chongqing Precision Biotech patents expire?

2 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.